TrialClinical and molecular hepatology2025

Safety and efficacy of HK-660S in patients with primary sclerosing cholangitis: A randomized double-blind phase 2a trial.

Woo Hyun Paik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.